NetEase (NTES) details Q2 2025 unaudited results in Form 6-K
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
NetEase, Inc. submitted a Form 6-K as a foreign private issuer for August 2025, stating it files annual reports on Form 20-F. The report mainly furnishes Exhibit 99.1, in which NetEase announces its unaudited financial results for the second quarter of 2025.
Positive
- None.
Negative
- None.
FAQ
What does NetEase’s August 2025 Form 6-K for NTES cover?
The August 2025 Form 6-K from NetEase, Inc. furnishes an exhibit announcing its unaudited financial results for the second quarter of 2025. It is a foreign issuer update rather than a full annual report, which NetEase files separately on Form 20-F.
Which financial period is referenced in NetEase’s latest Form 6-K?
The Form 6-K references second quarter 2025 unaudited financial results through Exhibit 99.1. While detailed numbers are not in the summary, the exhibit is intended to provide investors with quarterly performance information for that specific period of NetEase’s operations.
What exhibit is included with NetEase’s August 2025 Form 6-K?
NetEase’s August 2025 Form 6-K includes Exhibit 99.1, titled “NetEase Announces Second Quarter 2025 Unaudited Financial Results.” This exhibit contains the company’s detailed quarterly figures and disclosures, which are only referenced, not reproduced, in the brief cover information provided.
How does NetEase classify itself in this Form 6-K filing?
NetEase, Inc. identifies as a foreign private issuer and indicates it files annual reports under cover of Form 20-F. This classification affects the company’s reporting framework, including the use of Form 6-K for interim disclosures like quarterly financial updates.
Who signed NetEase’s August 2025 Form 6-K and in what role?
The Form 6-K is signed by William Lei Ding, who is identified as Chief Executive Officer of NetEase, Inc. His signature indicates authorization of the report’s submission under the Securities Exchange Act, dated in mid-August 2025 as part of routine regulatory compliance.